Atrial fibrillation represents a significant and growing economic burden on the UK healthcare system, accounting for nearly 1% of total NHS expenditure by 2000.
AF imposes a growing economic burden on health systems; leaves open the need for updated economic evaluations of contemporary AF therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: